• Product NameTrans-Tranilast
• Brief DescriptionInhibitors
• Purification98.00%
• Biological ActivityTrans-Tranilast is an antiallergic drug, used to treat bronchial asthma, allergic rhinitis and atopic dermatitis.
• Target NameRAAS antagonist
• CAS No. 70806-55-2
• Calculated MW 327.33
• Formulation C18H17NO5
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:COC1=C(C=C(C=C1)/C=C/C(=O)NC2=CC=CC=C2C(=O)O)OC
  Pathways:Endocrinology/Hormones
  Receptor:Angiotensin Receptor
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Rogosnitzky, MR, et al. AntiY Res, 2012. 32(7): p. 2471-8.2. Swiderski, K, et al. Fibrogenesis Tissue Repair, 2014. 7(1): p. 1.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting